Mem Inst Oswaldo Cruz, Rio de Janeiro, FAST TRACK
Short communication

Low risk of serological cross-reactivity between dengue and COVID-19 

Michele Spinicci1,2,+, Alessandro Bartoloni1,2, Antonia Mantella1, Lorenzo Zammarchi1,2, Gian Maria Rossolini1,3, Alberto Antonelli1,3

1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
3Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy

DOI: 10.1590/0074-02760200225
405 views 289 downloads

In the near future, the overlap of COVID-19 and dengue epidemics is a concrete threat in tropical regions. Co-epidemics of COVID-19 and dengue could be an overwhelming challenge for health systems in low- and middle-income countries. In this work, we investigated potential serological cross-reactions between COVID-19 and dengue patients. Further data on accuracy of COVID-19 diagnostic test are urgently warranted.

+ Corresponding author:
Received 10 May 2020
Accepted 13 May 2020

Our Location

Memórias do Instituto Oswaldo Cruz

Av. Brasil 4365, Castelo Mourisco 
sala 201, Manguinhos, 21040-900 
Rio de Janeiro, RJ, Brazil

Tel.: +55-21-2562-1222

This email address is being protected from spambots. You need JavaScript enabled to view it.

Support Program


fiocruz governo
faperj cnpq capes